2022
DOI: 10.3390/jcm11123337
|View full text |Cite
|
Sign up to set email alerts
|

Comment on Topyła-Putowska et al. Echocardiography in Pulmonary Arterial Hypertension: Comprehensive Evaluation and Technical Considerations. J. Clin. Med. 2021, 10, 3229

Abstract: A comprehensive PAH echocardiographic examination of patients with pulmonary arterial hypertension (PAH) should include a set of parameters resembling the pathophysiological changes occurring in the course of the disease. This approach could help clinicians build a complete picture of the patient, test the effects of targeted therapies and identify patients who need a more aggressive therapeutic approach to achieve a low risk-status.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

0
1
0

Year Published

2022
2022
2023
2023

Publication Types

Select...
2

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(1 citation statement)
references
References 13 publications
0
1
0
Order By: Relevance
“…A comprehensive review on the role of echocardiography in PAH that includes technical information on the new techniques in use, and emphasizes the need for testing, standardization and precise methodology offers useful detailed information on the technique [ 7 ]. The related comment by Manzi et al, that followed, emphasizes the need of including in the echocardiographic testing indices reflecting the pathophysiological changes that occur in the process of the disease and which, most importantly, would test the effect of specific PAH therapies [ 8 ].…”
mentioning
confidence: 99%
“…A comprehensive review on the role of echocardiography in PAH that includes technical information on the new techniques in use, and emphasizes the need for testing, standardization and precise methodology offers useful detailed information on the technique [ 7 ]. The related comment by Manzi et al, that followed, emphasizes the need of including in the echocardiographic testing indices reflecting the pathophysiological changes that occur in the process of the disease and which, most importantly, would test the effect of specific PAH therapies [ 8 ].…”
mentioning
confidence: 99%